作為抗癌療法的嵌合抗原受體T細胞
- 专利权人:
- Purdue Research Foundation
- 发明人:
- LOW, Philip,CHU, Haiyan,LEE, Yong Gu
- 申请号:
- HK16103743.6
- 公开号:
- HK1215791A
- 申请日:
- 2016.04.01
- 申请国别(地区):
- HK
- 年份:
- 2016
- 代理人:
- 摘要:
- Cytotoxic lymphocytes expressing chimeric antigen receptors (CAR) that target and bind small conjugate molecules (SCM) are disclosed, as well as methods of using the cells and the SCMs in the treatment of cancer.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- CHIMERIC ANTIGEN RECEPTOR-EXPRESSING T CELLS AS ANTI-CANCER THERAPEUTICS
- CHIMERIC ANTIGEN RECEPTOR-EXPRESSING T CELLS AS ANTI-CANCER THERAPEUTICS
- CONJUGATED ANTIBODIES AGAINST LY75 FOR THE TREATMENT OF CANCER
- CONJUGATED ANTIBODIES AGAINST LY75 FOR THE TREATMENT OF CANCER
- Conjugated antibodies against LY75 for the treatment of cancer